{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:14:35Z","timestamp":1778246075127,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cca.2013.07.024","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T11:47:22Z","timestamp":1375184842000},"page":"148-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Vitamin D activities and metabolic bone disease"],"prefix":"10.1016","volume":"425","author":[{"given":"Jackson W.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.07.024_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1747-0080.12030","article-title":"2013: where do the hypebole end and the facts begin?","volume":"70","author":"Morris","year":"2013","journal-title":"Nutr Diet"},{"key":"10.1016\/j.cca.2013.07.024_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Bischoff-Ferrari","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.07.024_bb0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00198-012-2224-2","article-title":"Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study","volume":"24","author":"Prentice","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cca.2013.07.024_bb0020","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1016\/S0021-9258(17)40189-X","article-title":"Specific cytosol-binding protein for 1,25-dihydroxyvitamin D3 in rat intestine","volume":"252","author":"Kream","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.024_bb0025","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1016\/S0021-9258(18)43337-6","article-title":"Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3","volume":"256","author":"Howard","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.024_bb0030","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.bone.2005.01.012","article-title":"Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels","volume":"36","author":"Anderson","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.cca.2013.07.024_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2010.03.048","article-title":"The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts","volume":"121","author":"Kogawa","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cca.2013.07.024_bb0040","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.nutr.22.120501.150216","article-title":"Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation","volume":"22","author":"Omdahl","year":"2002","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.cca.2013.07.024_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(01)25465-8","article-title":"An experimental investigation on rickets","volume":"193","author":"Mellanby","year":"1919","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.07.024_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D, deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.07.024_bb0055","series-title":"Committee to Review Dietary Reference Intakes for Vitamin D and Calcium","author":"Ross","year":"2011"},{"key":"10.1016\/j.cca.2013.07.024_bb0060","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2013.07.024_bb0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.45.070176.003215","article-title":"Metabolism and mechanism of action of vitamin D","volume":"45","author":"DeLuca","year":"1976","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cca.2013.07.024_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1677\/jme.1.01654","article-title":"Response of the 5\u2032-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model","volume":"34","author":"Hendrix","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.cca.2013.07.024_bb0075","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1359\/jbmr.080607","article-title":"Vitamin D metabolites and calcium absorption in severe vitamin D deficiency","volume":"23","author":"Need","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2013.07.024_bb0080","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1359\/jbmr.080616","article-title":"Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model","volume":"23","author":"Anderson","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2013.07.024_bb0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5694\/j.1326-5377.1984.tb108222.x","article-title":"Vitamin D and femoral neck fractures in elderly South Australian women","volume":"140","author":"Morris","year":"1984","journal-title":"Med J Aust"},{"key":"10.1016\/j.cca.2013.07.024_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2458-10-331","article-title":"Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"10","author":"Lai","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cca.2013.07.024_bb0095","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ajcn\/46.6.1005","article-title":"Determinants of vitamin D status in patients with hip fracture and in elderly control subjects","volume":"46","author":"Lips","year":"1987","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cca.2013.07.024_bb0100","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in the elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.07.024_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s001980200023","article-title":"Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study","volume":"13","author":"Chapuy","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cca.2013.07.024_bb0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.07.024_bb0115","first-page":"15","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis","author":"Avenell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cca.2013.07.024_bb0120","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/jc.2006-2664","article-title":"Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency","volume":"92","author":"Kim","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2013.07.024_bb0125","first-page":"56","article-title":"Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion","volume":"1","author":"Huang","year":"2002","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cca.2013.07.024_bb0130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bone.2007.02.024","article-title":"Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3","volume":"40","author":"Atkins","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.cca.2013.07.024_bb0135","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/1381612043383818","article-title":"Osteoblast differentiation and control by vitamin D and vitamin D metabolites","volume":"10","author":"van Driel","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cca.2013.07.024_bb0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jsbmb.2006.12.084","article-title":"RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells","volume":"103","author":"Anderson","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cca.2013.07.024_bb0145","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jbmr.298","article-title":"Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1\/1alpha-hydroxylase","volume":"26","author":"Geng","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2013.07.024_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1677\/jme.0.0310123","article-title":"Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase\u2013polymerase chain reaction","volume":"31","author":"Anderson","year":"2003","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.cca.2013.07.024_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2004.03.089","article-title":"Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D","volume":"89\u201390","author":"Anderson","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cca.2013.07.024_bb0160","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1210\/en.2010-0334","article-title":"Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption","volume":"151","author":"Kogawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.07.024_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsbmb.2012.09.008","article-title":"Modulation of osteoclastic migration by metabolism of 25(OH)-vitamin D(3)","volume":"136","author":"Kogawa","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cca.2013.07.024_bb0170","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/endo.142.7.8281","article-title":"Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets","volume":"142","author":"Dardenne","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.07.024_bb0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S8756-3282(03)00023-1","article-title":"Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1)","volume":"32","author":"Dardenne","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.cca.2013.07.024_bb0180","first-page":"S590","article-title":"Increased bone volume in the bone-specific CYP27B1 transgenic mouse","volume":"22","author":"Turner","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cca.2013.07.024_bb0185","first-page":"S151","article-title":"Enhanced vitamin D synthesis in osteoblasts protects against age-related bone loss","author":"Anderson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2013.07.024_bb0190","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0022-3476(79)80139-0","article-title":"Rickets with alopecia: an inborn error of vitamin D metabolism","volume":"94","author":"Rosen","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.cca.2013.07.024_bb0195","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(80)92763-4","article-title":"End-organ resistance to 1,25-dihydroxycholecalciferol","volume":"1","author":"Liberman","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.07.024_bb0200","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1056\/NEJM197805042981804","article-title":"Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D","volume":"298","author":"Brooks","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.07.024_bb0205","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cca.2013.07.024_bb0210","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng0897-391","article-title":"Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning","volume":"16","author":"Yoshizawa","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.cca.2013.07.024_bb0215","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","article-title":"Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses","volume":"140","author":"Amling","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.07.024_bb0220","first-page":"139","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.07.024_bb0225","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.07.024_bb0230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.gastro.2008.12.051","article-title":"Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice","volume":"136","author":"Xue","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cca.2013.07.024_bb0235","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/mend.16.7.0866","article-title":"Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D","volume":"16","author":"Erben","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cca.2013.07.024_bb0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP64098","article-title":"The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure\u2014actions of a permissive hormone","volume":"64","author":"Cochran","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cca.2013.07.024_bb0245","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI200319826","article-title":"Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5","volume":"112","author":"Hoenderop","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2013.07.024_bb0250","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","article-title":"Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis","volume":"279","author":"Panda","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.024_bb0255","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/en.2012-1542","article-title":"Vitamin D receptor in osteoblasts is a negative regulator of bone mass control","volume":"154","author":"Yamamoto","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2013.07.024_bb0260","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1096\/fj.99-1075com","article-title":"Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage","volume":"14","author":"Gardiner","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2013.07.024_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00223-002-2139-6","article-title":"Targeted overexpression of vitamin D receptor in osteoblasts increases calcium concentration without affecting structural properties of bone mineral crystals","volume":"73","author":"Misof","year":"2003","journal-title":"Calcif Tissue Int"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:44:39Z","timestamp":1757861079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":53,"alternative-id":["S0009898113002921"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.024","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D activities and metabolic bone disease","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}